• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Transcription elongation factor A protein 3 (TCEA3)

ACP21062

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP21062 Target NameTCEA3
FormLyophilized powderExpression SystemCustom Production. Please inquire and provide the desire expression system.
Expression Range1-348Protein LengthFull length protein
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDO75764
Background Information
  • Uniprot Id

    O75764

  • Target Species

    Human

  • Target Name

    TCEA3

  • Target Full Name

    Transcription elongation factor A protein 3

  • Target Function

    Necessary for efficient RNA polymerase II transcription elongation past template-encoded arresting sites. The arresting sites in DNA have the property of trapping a certain fraction of elongating RNA polymerases that pass through, resulting in locked ternary complexes. Cleavage of the nascent transcript by S-II allows the resumption of elongation from the new 3'-terminus.

  • Target Subcellular Location

    Nucleus.

  • Target Protein Families

    TFS-II family

  • Target Synonyms

    Rhabdomyosarcoma antigen MU RMS 40.22; Tcea3; TCEA3_HUMAN; TFIIS; TFIIS.H; Transcription elongation factor A (SII) 3; Transcription elongation factor A protein 3; Transcription elongation factor A3; Transcription elongation factor S-II protein 3; Transcription elongation factor TFIIS.h

Inquire Recombinant Human Transcription elongation factor A protein 3 (TCEA3) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification